Skip to main content
. 2015 Feb 24;6(6):4440–4450. doi: 10.18632/oncotarget.2913

Figure 4. Cumulative survival of the hepatocellular carcinoma (HCC) patients by treatment in the two considered periods 2002–2006 (P1) and 2007–2011 (P2).

Figure 4

(A) Liver transplantation. (B) Surgical resection. (C) Transcatheter arterial chemoembolization (TACE). (D) Percutaneous local ablation. (E) Systematic therapy. (F) Supportive care. (G) Other therapy.